Thinking of taking your company public? Get our essential guide to a successful IPO. Download Now

Westicke Partners

Close

ICR Westwicke Blog

The ICR Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

What is an 8K and how do you read one?

Posted on July 8th, 2021. Posted by

what-is-an-8k-and-how-do-you-read-one

What is an 8-K?

Form 8-K, also known as an 8K, is a form that is filed by public companies to notify their shareholders and the Securities and Exchange Commission (SEC) when an unscheduled material event takes place. In other words, it’s an announcement that a major event or corporate change that may be of interest to investors, has occurred. Form 8K is known as a “current report” and is filed in addition to an annual report on Form 10-K and a quarterly report on Form 10-Q.

Continue Reading

Top 10 Questions to Ask Sell-Side Analysts

Posted on June 21st, 2021. Posted by

top 10 questions for sell-side analysts

There’s a saying in investor relations: “You date your investment bankers, but you marry your research analysts.” Essentially, this means that a sell side analyst who covers your company will remain your partner for the long run. Investment bankers, on the other hand, work with a long list of companies and deal with jam-packed, demanding schedules. They don’t disappear after the initial public offering (IPO), but the time they can devote to your company diminishes.

Continue Reading

How to Host an Effective R&D Day: 5 Key Elements

Posted on June 9th, 2021. Posted by

Hosting an R&D Event

A well-planned and executed research and development (R&D) day can reinforce a company’s message, heighten a company’s visibility, and allow a management team to highlight their investment thesis. It can be an effective and efficient investor relations tool if done correctly.

Continue Reading

The Evolution of SPACs: New Challenges and Opportunities

Posted on May 20th, 2021. Posted by

Evolution of SPAC

Special purpose acquisition company (SPAC) activity has exploded in the past two years, from 59 transactions in 2019, to 248 deals in 2020, to 308 SPACs so far in 2021. However, SPACs are not new. This type of transaction has been around for decades, continually evolving as it rises and falls in popularity.

Continue Reading

What to Know About Going Public Through an IPO, SPAC, or Direct Listing

Posted on May 6th, 2021. Posted by

Going Public: IPO, SPAC, or Direct Listing?

Going public is a transformational event that gives companies the capital they need to invest in future growth, attract top talent, and raise their profile, while providing liquidity to investors and employees.

Continue Reading

Quiet Periods FAQ: What You Need to Know

Posted on April 22nd, 2021. Posted by

Quiet Periods

Unlike quiet periods following an IPO, which are closely regulated by the Securities and Exchange Commission (SEC), end-of-quarter quiet periods are more loosely defined and not strictly regulated.

Continue Reading

Top 10 Benefits Of Non-Deal Road Shows

Posted on April 8th, 2021. Posted by

Top 10 Benefits of Non-Deal Road Shows

Right after you report earnings is the ideal time to get out on the road and tell your story to the Street. Sell-side analysts are incentivized to market with management teams, so they are always willing to sponsor a non-deal road show (NDRS).

Continue Reading

The Evolution of the Retail Investor and Sentiment Trading

Posted on March 18th, 2021. Posted by

Retail Investors

In 2018, we wrote a piece on best practices to manage and communicate with the growing retail investor community. While the basic tenants of those recommendations hold today, the retail investor has fundamentally changed over the last couple of years.

Continue Reading

Form 8-K or Press Release: Know the Difference When You Disclose News

Posted on March 4th, 2021. Posted by

Form 8-k or Press Release

One of our clients, a recently public diagnostics company, settled an ongoing royalty dispute with a major pharmaceutical company. The settlement amount was significantly lower than what our client had accrued, resulting in nearly $750 thousand upside to their P&L in the upcoming quarter.

Continue Reading

Our Most-Read Investor Relations Posts of 2020

Posted on February 23rd, 2021. Posted by

Top 2020 Westwicke Content

No one would argue that 2020 was unique and challenging for almost every industry, including healthcare. The year forced both public and private companies to reconsider many aspects of how they do business and communicate with the investment community. As we all adapted and learned, our Westwicke blog covered a variety of investor relations topics, both pandemic related and not. Below are some of the most popular blog posts we published this year.

Continue Reading

1 4 5 6 7 8 30

Have News to Release?

Find out whether you should file a Form 8-K, issue a press release, or do both by using our easy-to-reference chart, “Form 8K vs. Press Release: What’s the Difference?

Our Locations